• 9731 Citations
  • 38 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Outputs

Filter
Review article

Use of targeted therapies for advanced renal cell carcinoma in the asia-pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia

Ye, D., Eto, M., Chung, J. S., Kimura, G., Chang, W. C., Chang, Y. H., Pang, S. T., Lee, J. L., Niu, Y., Gurney, H. & Uemura, H., Aug 2014, In : Clinical Genitourinary Cancer. 12, 4, p. 225-233 9 p.

Research output: Contribution to journalReview article

16 Citations (Scopus)

The adverse effects of androgen deprivation therapy in prostate cancer and the benefits and potential anti-oncogenic mechanisms of progressive resistance training

Lam, T., Birzniece, V., McLean, M., Gurney, H., Hayden, A. & Cheema, B. S., 13 Feb 2020, In : Sports Medicine - Open. 6, 1, p. 1-14 14 p., 13.

Research output: Contribution to journalReview article

Open Access
File
2 Citations (Scopus)
2 Downloads (Pure)

Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management

Desai, J., Gurney, H., Pavlakis, N., Mcarthur, G. A. & Davis, I. D., Dec 2007, In : Asia-Pacific Journal of Clinical Oncology. 3, 4, p. 167-176 10 p.

Research output: Contribution to journalReview article

12 Citations (Scopus)

Nuances to precision dosing strategies of targeted cancer medicines

Hopkins, A. M., Menz, B. D., Wiese, M. D., Kichenadasse, G., Gurney, H., McKinnon, R. A., Rowland, A. & Sorich, M. J., 1 Aug 2020, In : Pharmacology Research & Perspectives. 8, 4, 9 p., e00625.

Research output: Contribution to journalReview article

Open Access
File

Moving towards dose individualization of tyrosine kinase inhibitors

Klümpen, H. J., Samer, C. F., Mathijssen, R. H. J., Schellens, J. H. M. & Gurney, H., Jun 2011, In : Cancer Treatment Reviews. 37, 4, p. 251-260 10 p.

Research output: Contribution to journalReview article

76 Citations (Scopus)

Metformin in prostate cancer: Two for the price of one

Clements, A., Gao, B., Yeap, S. H. O., Wong, M. K. Y., Ali, S. S. & Gurney, H., Dec 2011, In : Annals of Oncology. 22, 12, p. 2556-2560 5 p., mdr037.

Research output: Contribution to journalReview article

47 Citations (Scopus)

Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure

Rowland, A., van Dyk, M., Mangoni, A. A., Miners, J. O., McKinnon, R. A., Wiese, M. D., Rowland, A., Kichenadasse, G., Gurney, H. & Sorich, M. J., 2017, In : Expert Opinion on Drug Metabolism and Toxicology. 13, 1, p. 31-49 19 p.

Research output: Contribution to journalReview article

31 Citations (Scopus)

Inhibitors of mTOR

Klümpen, H. J., Beijnen, J. H., Gurney, H. & Schellens, J. H. M., Dec 2010, In : Oncologist. 15, 12, p. 1262-1269 8 p.

Research output: Contribution to journalReview article

46 Citations (Scopus)

Hemopoietic growth factors: Their clinical role

Gurney, H. & Crowther, D., 1990, In : Drugs of the Future. 15, 6, p. 581-595 15 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Evidence for therapeutic drug monitoring of targeted anticancer therapies

Gao, B., Yeap, S., Clements, A., Balakrishnar, B., Wong, M. & Gurney, H., 10 Nov 2012, In : Journal of Clinical Oncology. 30, 32, p. 4017-4025 9 p.

Research output: Contribution to journalReview article

129 Citations (Scopus)

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice - part 1

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Jan 1993, In : Annals of Oncology. 4, 1, p. 23-34 12 p.

Research output: Contribution to journalReview article

37 Citations (Scopus)

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice -part 2

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Feb 1993, In : Annals of Oncology. 4, 2, p. 103-115 13 p.

Research output: Contribution to journalReview article

38 Citations (Scopus)

Dose considerations for anti-cancer drugs in metastatic prostate cancer

Crumbaker, M. & Gurney, H., 1 Aug 2017, In : Prostate. 77, 11, p. 1199-1204 6 p.

Research output: Contribution to journalReview article

3 Citations (Scopus)

Dose calculation of anticancer drugs

Gao, B., Klumpen, H. J. & Gurney, H., Oct 2008, In : Expert Opinion on Drug Metabolism and Toxicology. 4, 10, p. 1307-1319 13 p.

Research output: Contribution to journalReview article

30 Citations (Scopus)

Dose calculation of anticancer drugs: A review of the current practice and introduction of an alternative

Gurney, H., 1996, In : Journal of Clinical Oncology. 14, 9, p. 2590-2611 22 p.

Research output: Contribution to journalReview article

292 Citations (Scopus)

Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia

Parente, P., Gurney, H., Ng, S. & Bahre, M., 1 Sep 2015, In : Asia-Pacific Journal of Clinical Oncology. 11, 3, p. 199-207 9 p.

Research output: Contribution to journalReview article

4 Citations (Scopus)

Clinical concepts for cabazitaxel in the management of metastatic castration-resistant prostate cancer

Al-Mansouri, L. & Gurney, H., 1 Dec 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, 6, p. 288-295 8 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer

Parente, P., Parnis, F. & Gurney, H., Sep 2014, In : Asia-Pacific Journal of Clinical Oncology. 10, 3, p. 205-215 11 p.

Research output: Contribution to journalReview article

6 Citations (Scopus)

Allogeneic bone marrow transplant for refractory mediastinal germ cell tumour: Possible evidence of graft-versus-tumour effect

Goodwin, A., Gurney, H. & Gottlieb, D., Feb 2007, In : Internal Medicine Journal. 37, 2, p. 127-129 3 p.

Research output: Contribution to journalReview article

2 Citations (Scopus)